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1. Introduction 
Skeletal muscle accounts for approximately 50% of total body weight, and is known to be 
the largest tissue in the human body, mainly responsible for force generation, movement 
and breathing [1,2]. The muscles consist of four main types of fibers, type 1, 2A, 2D/X and 
2B, which differ in their contractile and metabolic properties. This difference is dependent 
on the myosin heavy chain (MHC) isoform that predominates in each fiber type and the 
gene expression program, and therefore the distribution of fiber types is genetically 
determined [2,3]. 
The various muscle functions are controlled by signaling pathways that allow the muscle 
fiber respond to changes in the metabolic and functional demands of the body. Indeed, 
examples in the world of sports, therapy, surgery, and trauma support the idea that skeletal 
muscle is one of the most adaptable tissues in the body.  
Skeletal muscle response varies whether the level of use increases or decreases. In fact, 
muscles are always trying to tailor their molecular, structural and functional properties to 
the level of use demanded of them. However, there are situations which the level of use, 
metabolic load, or the level of stress on a muscle fiber is so great that the fiber suffers 
damage, in which part of the muscle cell degenerates and is replaced with new muscle 
tissue. Such a response has important implications for the normal development process, the 
potential use of regenerating muscle in treatment of muscle disease and in sports 
performance [4]. 
Recently, a large number of studies have suggested that some diseases such as cancer, 
diabetes and AIDS [5,6], and unfavorable environmental conditions, such as 
immobilization and fasting can lead to reduction in skeletal muscle mass, known as 
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muscle atrophy [7]. In contrast, some forms exercise training, such as strength training 
and resistance training, can produce an increase in skeletal muscle mass, known as muscle 
hypertrophy [8]. These interactions suggest that the dynamic regulation of skeletal muscle 
mass is not simply a balance between synthesis and protein degradation, but a finely 
regulated process.  
Skeletal muscle hypertrophy is known to increase the cross-sectional area of skeletal muscle 
by biosynthesis of new structures involved in muscle contraction, known as one of the main 
alterations generated in the muscle as a result of exercise training [9,10]. 
The development of molecular biology techniques have allowed major advances in 
understanding the intracellular signaling pathways responsible for regulating skeletal 
muscle tropism and their adaptations to different types of exercise training. Thus, several 
studies have recently been published addressing this topic with great richness of detail [1,9-
12]. 
The synthesis of new contractile units takes place by known processes, and studies of 
information about gene flow have shown that this begins with the replication, 
maintenance and rearrangement of DNA, through synthesis and RNA processing 
(transcription) and culminating with the synthesis and processing of regulatory proteins 
(translation) [13,14]. These processes are sequential, capable of regulating skeletal muscle 
mass at various points and in response to a chronic stimulus, such as exercise training. 
They can lead to an over-compensatory response to this stimulus resulting in the 
formation of new contractile muscle units, which will lead to increased muscle size and 
strength. This remodeling that occurs in skeletal muscle involves intracellular signaling 
pathways and consequent gene reprogramming that results in changes in mass, 
contractile and metabolic properties. 
The main pathways responsible for a biochemical cascade of intracellular signaling will be 
addressed in this review with purpose of providing an integrated view of processes that 
promote the increase or decrease the size of the muscle fibers resulting from exercise 
training. Therefore, various intracellular signaling pathways involved in regulation of 
skeletal muscle mass induced by exercise training have been reported in the literature, and 
the main focus of this chapter was to review processes, such as the Akt-mTOR pathway, 
myostatin and microRNAs (miRNAs). 
2. Signaling pathways involved in muscle remodeling 
Skeletal muscle responds to physiological stimuli such as exercise training, and remodels to 
adapt to new demands imposed by this stimulus. This adjustment is made by extracellular 
stimuli to reach the cell membrane and interact with receptors activating intracellular 
signaling pathways, which result in changes in gene transcription and protein synthesis and 
thus promote muscle remodeling. In this review, some of the most important intracellular 
pathways are presented. 
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3. Exercise training and the Akt-mTOR pathway  
Protein synthesis is regulated at several levels and involves a complex biological network of 
intracellular signaling mechanisms. The signaling pathway IGF-1/PI3K/Akt (growth factor 
like Insulin-1, phosphatidylinositol 3-kinase and protein kinase B, respectively) is 
considered the main mediator of normal muscle development and one of the most studied 
signaling molecular systems involved in muscle hypertrophy. This pathway plays a key role 
in the hypertrophic process, since it coordinates the molecular basis related to protein 
degradation and synthesis [7,9,10,15-21]. 
The Akt family is composed of three members: Akt1 (PKB-α) Akt2 (PKB-β) and Akt3 
(PKBγ). These three isoforms share over 80 % homology and are expressed in a tissue 
specific manner, thus the Akt1 and Akt2 isoforms are predominantly expressed in skeletal 
muscle, the brain, heart and lungs and Akt3 is more expressed in the brain and testicles 
[22,23]. 
There are various stimuli that lead to the activation/phosphorylation of Akt: such as growth 
factors [24], cytokines, hormones, which occurs in a manner dependent on 
phosphatidylinositol 3 kinase (PI3K) [25], suggesting that Akt plays an important role in 
mitogenic cellular function and protein synthesis. In fact, studies with knockout transgenic 
mice for Akt1, have shown deficiency in muscle growth [26] and mice that overexpressed 
Akt1 have resulted in a hypertrophic skeletal muscle phenotype [27]. Specifically in skeletal 
muscle, expression of the active isoform of Akt1 results in in vitro and in vivo myotube 
hypertrophy, and also prevents atrophy in denervated muscles [7].  
Another stimulus capable of inducing components of this pathway independently of 
agonists is called mechanotransduction, which consists of conversion of the mechanical 
signal into a biochemical event, and it also plays a key role in inducing protein synthesis. 
Thus, mechanical signal transduction is also capable of inducing growth by means of a 
mechanism other than growth factor signaling, which is independent of upstream elements 
such as IGFI and PI3K [28] 
The strength training consists of mechanical stimuli and is a potent agent that increases 
tropism in the skeletal muscle. This increase is triggered by increase in IGFI or MGF 
(mechano growth factor) protein expression which leads to a sequential activation cascade, 
ordered by PI3K, PDKI and II (phosphoinositide dependent kinase I and II) and Akt. After 
this, Akt promotes activation of two independent pathways: mTOR (mammalian target of 
rapamycin) and GSK3β (glycogen synthase kinase-3β) that play a crucial role in skeletal 
muscle hypertrophy [18]. 
PI3K is an enzyme highly expressed in skeletal muscle and its primary activity is the 
phosphorylation of some lipids (phosphatidylinositol) in position 3 of the inositide group 
(D3) [29]. Activation of Akt induced by strength training is a process that involves several 
steps and additional proteins. The activation of PI3K by IGFI/MGF results in 
phosphatidylinositol 3 phosphate (PIP3), which leads to translocation of Akt to the 
membrane and a conformational change that allows PDKI and PDKII to phosphorylate the 
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Ser473 and Thr308 residues activating Akt [30]. There is evidence that Thr308 is 
phosphorylated by PDKI and that the Ser473 residue can be phosphorylated by Akt, PDKII 
or other kinases that have not yet been discovered [30]. Once activated, Akt phosphorylates 
mTOR and GSK3β, which mediate protein synthesis, transcription and proliferative 
processes related to hypertrophy response, as well as control of protein degradation [10].  
The mTOR functions as a central integrator of a wide range of signals that modulate protein 
metabolism and cell growth. There is evidence that phosphorylation of mTOR induced by 
strength exercise training acts on protein translation on a global scale, since three 
downstream components of this pathway: p70s6k, 4E-BPI and eEF2 facilitates initiation of the 
translation process, mainly of mRNAs with complex secondary structures in the 
5´untransated region, promoting biogenesis of ribosome, respectively. P70s6K stimulates 
protein synthesis due to its action both on mRNA translation which has oligo-pyrimidine 
sequences in its 5´UTR region adjacent to CAP (m7GpppG) and also on the phosphorylation 
of the ribosomal peptide S6 by kinase p70S6k [15, 31]. 
Moreover, mTOR directly phosphorylates the protein 4E-BPI/PHAS-I. Once 
phosphorylated, it releases its inhibitory effect on the translation initiation factor elF4E, 
which impairs inhibition of translation initiation by coupling with the end CAP of mRNA. 
There is one last active effect of mTOR on increasing muscle mass that consists of its effect of 
decreasing phosphorylation of S6K kinase, leading to the increase in cross-sectional area of 
skeletal muscle [15,31]. 
The first evidence that mTOR and its activation of p70S6K could play a role in the mediation 
of hypertrophic effects induced by strength training was shown by Baar & Esser [32]. In this 
study the phosphorylation of p70S6k was increased in the tibialis anterior and extensor 
digitorum longus in 3 and 6 hours after the strength training session. Thus, the direct role of 
mechanical overload on the activation of this ribosomal unit was shown, as well as a direct 
correlation between the increase in p70S6k and the increase in muscle mass induced by 
strength training. 
Furthermore, definitive studies were conducted on the signaling mechanisms of mTOR in 
skeletal muscle hypertrophy, induced by strength training, with the use of rapamycin, a 
specific mTOR inhibitor. Some studies [33,34] used Sprague Dawley rats submitted to one 
strength exercise session, to assess the acute effect of this type of exercise. Increased protein 
synthesis was found in the gastrocnemius muscle 16 hours after the session, which was 
completely prevented by administration of rapamicyn used 2 hours before of the exercise 
session. In contrast to these results, recent studies have shown that aerobic exercise training 
increased the phosphorylation of protein kinases activated by AMP (AMPK), which directly 
phosphorylated TSC2 also known as Tuberin or Tuberous Sclerosis protein 2. This led to the 
inhibition of mTOR, which suggests that protein synthesis is inhibited in this type of 
training [18]. 
Furthermore, Akt is related to another pathway parallel to mTOR, which induces 
hypertrophy through phosphorylation in Serine 9 of GSK-3β [35]. When phosphorylated, 
GSK3β is inhibited, decreasing eIF2B in Serine 535 activity, which promotes the translation 
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initiation process [36], In fact, studies have reported the increase in GSK-3β 
phosphorylation, which leads to eIF2B inhibition immediately after and 3 hours after a 
strength training session, supporting hypothesis that this pathway is also involved in the 
stimulation of protein synthesis induced by strength training [18,37]. 
Although the role of this pathway in strength exercise-induced hypertrophy has been 
established, the contributions of individual pathways regulating mTOR during mechanical 
overload-induced skeletal muscle hypertrophy are poorly defined and there are several 
controversial results related to exercise. A recent study showed that 10 days of mechanical 
overload induced progressive hypertrophy of the plantaris muscle and this growth was 
associated with significant increases in total RNA content and protein metabolism in 
C57BL/6J mice. Inhibition of PI3K activity by wortmannin was sufficient to block insulin-
dependent signaling, but did not prevent the early activation of mTOR in response to 
overload. Akt phosphorylation and GSK3β, were not significantly increased until 2-3 days 
of overload had occurred. In contrast, mTOR was activated after a single day of overload as 
indicated by a significant increase in S6K1 phosphorylation [38]. In addition, the mitogen-
activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent 
pathway was activated at day 1 after overload, which provided evidence that the MEK/ERK 
pathway may contribute to mTOR activation through the phosphorylation of TSC2 [38]. 
However, it is not clear whether this is the main mechanism that activates mTOR [39]. This 
study demonstrated an independent activation of P70S6k and cross-talk between MEK/ERK 
and mTOR pathways that may provide elucidation about skeletal muscle growth in 
response of exercise training in future.  
A third important function of Akt in skeletal muscle tropism is the regulation of the 
transcription through inactivation of Forkhead Transcription Factors, also called FOXO or 
FKHR, which are responsible for gene transactivation involved in components of the 
proteolytic system coordinated by the ubiquitin-proteasome system [40,41].  
Three FOXO isoforms have been investigated and have been well characterized FOXO-I, 
FOXO-3a and FOXO-4 [42]. The FOXO isoforms are predominantly located in the nucleus 
where they are activated. However, when they are phosphorylated, mainly by Akt protein, 
these FOXO proteins are extruded to cytosol, and they are not capable of inducing the 
transcription of genes involved in muscle atrophy, such as atrogin-I/MAFbx and MuRF, two 
specific muscle E3 ligases, that are components of the ubiquitin proteasome system [43-45]. 
Studies have shown that when Akt pathway signaling is inhibited there is an increase in 
atrogin-I transcription, and also inversely, FOXO-I expression is reduced in hypertrophy 
[16,17]. These results strongly suggest that that skeletal muscle hypertrophy induced by 
strength training in healthy individuals is at least partly related to FOXO-I inhibition by Akt.  
The effect of detraining was also studied, and inversely to that which was observed in 
response to strength training, the signaling described for Akt phosphorylation decreased 
[17] and there was a decrease in GSK3β phosphorylation, which emphasizes that this 
pathway is also involved in the skeletal muscle atrophy process induced by the interruption 
of strength training. 
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In addition, there is evidence that the activation of this pathway is dependent on age, 
gender, variations in the type and intensity of the exercise performed, mode of contraction 
(concentric/eccentric). Moreover, differences in type I and type II fibers activated in force 
development influence the phosphorylation of these key signaling proteins [32,46,47].  
Studies have shown that strength training is capable of activating the Akt pathway acutely 
and chronically, in a predominant and specific manner when compared with endurance 
training [17-19;48]. However, there are studies showing that it is a key pathway to cardiac 
physiological hypertrophy induced by swimming exercise in mice, which also suggests a 
tissue dependent activation [49] (Figure1). 
 
Figure 1. Signalling pathways regulated by exercise and/or IGF-I. Exercise has been shown to activate 
Akt and ERK1/2 directly, and also induces IGF-I synthesis in muscle. PI3K/Akt is of particular 
importance as it increases protein synthesis via mTOR activation and inhibits protein degradation via 
the inactivation of FOXO transcription factors with resistance training. AMPK-activation leads to PGC-
1α activation and induces mitochondrial biogenesis with endurance training. ERK = extracellular signal-
regulated protein kinase; mTOR = mammalian target of rapamycin; TSC2 = tuberous sclerosis complex 
2; PI3K = phosphatidylinositol 3-kinase; eIF2 = eukaryotic initiation factors 2; eIF = eukaryotic initiation 
factors, including 4E and 2B; 4EBP1 = 4E binding protein 1; ATP (adenosine triphosphate) AMPK = 
AMP (adenosine monophosphate)-activated protein kinase; MuRF1=muscle RING finger 1; FOXO = 
Forkhead box; PGC-1α= Peroxisome proliferator-activated receptor-γ coactivator 1α. 
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Strength/resistance training and some forms of intermittent high-intensity stimulation have 
been associated with an increase in protein synthesis and thus substantial muscle 
hypertrophy and gains in maximal force output, whereas endurance training does not 
promote skeletal muscle hypertrophy or increase the force-output ability of muscle [50]. 
Human subjects were divided into groups performing endurance training and strength 
training in a single-bout of exercise, and non-exercised control group. The protocol was 
conducted with an exercise mode in which the exercise subjects were accustomed during a 
prior training period of 10 weeks. Activation of several components of mTOR and its 
downstream signaling were activated exclusively by strength training, while AMPK and its 
substrate were activated only in endurance trained individuals. Whereas, the strength 
training produced a non significant increase in phosphorylated AMPK and did not increase 
activation of its substrates. It is known that AMPK activation may phosphorylate raptor, a 
mTOR complex component, and it has been suggested that this may switch off mTOR 
activity [51,52]. However, there have also been studies that have shown an increase in the 
Akt-mTOR pathway with endurance training [53]. It has been suggested that AMPK 
activation induced by endurance training also reduces energy consumption related to the 
protein synthesis process in situations that combine energy consuming exercise and fasting 
[51].  
In rats, AMPK vs. Akt-mTOR signaling divergence has been suggested to explain the 
conversion of endurance training stimulation into mitochondrial biogenesis and conversion 
of resistance training stimulation into muscle hypertrophy, respectively [18]. 
Research using experimental animals has indicated that type I and type II fibers might 
respond differently to contractile activity [19]. The increase in muscle size produced by 
regular performance of resistance exercise is largely due to an enhancement in the size of 
type II fibers [54]. Recreationally active male subjects performed four sets of six maximal 
lengthening contractions with one leg. Muscle biopsies were taken from the vastus lateralis 
before and immediately after exercise. After 1 and 2 hours of recovery, the elevation of 
p70S6k and the reduction in eIF2 phosphorylation in the type II fibers after resistance exercise 
suggest the stimulation of protein synthesis, which may contribute to a more pronounced 
enlargement of these fibers. In reference [21] it was observed that both concentric and 
eccentric contractions resulted in extensive phosphorylation of mTOR and p70S6k in the fast-
twitch muscles of the rat, while no effect on the slow-twitch soleus muscle was detected 
after concentric contractions. 
The mode of contraction, particularly in eccentric (lengthening) exercise has been considered 
important for muscle growth, due to inducing a greater amount of muscle fiber enlargement 
than concentric exercise after a period of immobilization [55]. In addition, at maximal 
intensities, protocols involving lengthening exercise stimulated myofibrillar protein 
synthesis more rapidly than shortening exercise [56]. In contrast, other studies have shown 
similar increases in muscle growth after concentric and eccentric exercise training, 
accompanied by the same increase in the rate of protein synthesis after exercise [57,58].  
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There is evidence that eccentric contraction induces a greater magnitude of hypertrophy 
than concentric contraction. A time course study conducted in the absence of nutritional 
supply [59] compared the effect of training stimuli of eccentric and concentric contraction 
modes on Akt/mTOR/p70s6k activation in human males, and reported that the eccentric 
contraction protocol resulted in greater activation of this pathway than the concentric 
protocol. Ten subjects performed four sets of six maximal one leg concentric, versus four 
sets of six maximal eccentric exercise of equal force on the other leg. Although there were no 
significant changes in phosphorylation of Akt and mTOR, the maximal eccentric protocol 
induced two to eightfold increases in phosphorylation of p70S6k and in ribosomal protein 
S6k, which persisted for two hours into recovery period. On the other hand, the concentric 
protocol or submaximal eccentric contractions did not increase phosphorylation in Akt and 
mTOR, and there was no phosphorylation in p70S6K and S6k up to two hours later. The 
authors suggested that an enhanced hypertrophic response to this mode of contraction may 
occur due to maximal eccentric contraction being able to activate p70S6k, independently of 
the Akt pathway, in addition to being more effective in simulating protein synthesis, an 
effect that can be induced by the combination of greater tension and stretching of the 
activated muscles. Indeed, the peak force produced by the eccentric contraction mode is 
greater and thus results in a increased force per active fiber, increasing mechanical stimulus 
to the muscle fiber which is known to activate this pathway [60,61].  
Recently, the influence of eccentric contraction velocities on Akt pathway and MGF 
expression was studied. The effect of eccentric contraction velocity manipulation on vastus 
lateralis hypertrophy was investigated in a study with twenty human males. The subjects 
performed five sets of 8 repetitions of a slow or fast eccentric protocol and biopsies were 
collected at the following time intervals: baseline, immediately after, and two hours after the 
session. MGF expression was increased approximately 2.5 fold in slow eccentric contraction, 
and Akt and p70s6K protein phosphorylation were higher in the fast eccentric protocol than 
at baseline, or slow or fast eccentric contraction, which suggests that the velocity has no 
direct influence on the activation of this pathway, and other signaling pathways could be 
selectively activated and involved in the response to high velocity eccentric contraction [62]. 
As skeletal muscle adaptation to exercise is highly dependent on the specificity of training 
performed, is interesting pay attention to concurrent training effects on this signaling 
pathway. The effects of a combination of one bout of endurance followed by strength 
exercise (concurrent training) on this Akt-mTOR pathway were studied by Wang et al. [53], 
who assessed whether resistance/strength exercise could change the molecular signaling 
response to endurance training in skeletal muscle. Although the authors had hypothesized 
that strength exercise would induce a downregulation of genes related to oxidative 
metabolism, strength exercise performed after the endurance exercise induced an increase in 
the expression of PGC-1α, PGC-1-related coactivator (mitochondrial biogenesis genes) and 
PDK4 (aerobic substrate regulation marker), one and three hours after completion of the 
exercise bout. AMPK phosphorylation was increased to a similar extent between the 
endurance and resistance/strength exercises at one hour post-exercise but was reversed at 
three hour post-exercise without difference between endurance and strength training [53]. 
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The acute molecular response to concurrent exercise was investigated in a protocol in which 
the individual performed resistance exercise either before or after endurance exercise and 
there was no increase in the phosphorylated form of AMPK, and only a modest but not 
significant increase in PGC-1α mRNA [63]. It was not clear if this different finding was due 
to interference from resistance exercise, or the change in the order of exercise, or whether the 
stimulus was low considering the training status of the subjects. Thus the controversy about 
whether adaptation to endurance training can be affected by the addition of resistance force 
remains, since both protocols used strength exercise. Although the consecution of resistance 
exercise seems be an enhancer of the acute effects of endurance training in the first study, 
whereas the order of stimuli was inverted only in the second study, the absence of 
difference could be due a similar number of stimuli.  
Protein synthesis and muscle adaptation are regulated in a different manner with aging in 
different muscle types and genders. Age related atrophy or sarcopenia is thought to be a 
consequence of normal aging and it is characterized by decreased muscle strength, reduced 
performance and a decreased capacity to induce hypertrophy after an increase in muscle 
loading [64]. The Akt-mTOR signaling pathway and its important components associated 
with the induction of muscle hypertrophy are attenuated with aging [21]. Decreased mTOR, 
p70S6K, 4E-BP1, and ribosomal protein S6 phosphorylation have been reported after 7 days of 
muscle overload in aged animals in comparison with young adult animals [65,66].  
Little is known about gender-based differences in muscle protein synthesis [67]. It has 
been shown that muscle protein synthesis is similar in healthy young men and women 
and that resistance exercise induced increase in muscle protein synthesis and mTOR 
signaling irrespective of sex. A recent study [68] that examined the acute response to 
resistance exercise in leg muscle, showed that protein synthesis was significantly 
increased by 52% in young men and by 47% in young women during the first 2 hours of 
post-exercise recovery.  
In conclusion, there are many results that explain the mechanisms involved in regulating the 
increase in muscle mass induced by exercise training. The Akt-mTOR signaling pathway is 
capable of coordinating anabolic and catabolic pathways, leading to an increased 
hypertrophy or atrophy response, which can contribute to elucidating the importance of 
exercise training in future pharmacological and clinical interventions. 
4. Exercise training and myostatin 
Myostatin, also called growth and differentiation factor-8, is a member of Transforming 
Growth Factor-beta superfamily (TGF-β) that functions as a regulator of muscle mass 
[69,70]. Myostatin expression is identified during the early stages of embryogenesis and 
continues to be expressed during development of skeletal muscle. In later stages and in 
adult animals, myostatin is predominantly expressed in skeletal muscle and adipose tissue. 
However, using a more sensitive real time-PCR techniques, myostatin transcripts could also 
be detected in the heart and mammary tissues [71]. 
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Several studies showed that myostatin overexpression reduce muscle mass, fiber size, and 
myonuclei number [72,73]. On the other hand, blockade of myostatin resulted in excessive 
growth and increased force generation of skeletal muscle indicating that this member of the 
TGF-β superfamily is a negative regulator of skeletal muscle hypertrophy [69,70,74,75]. 
Studies with myostatin knockout mice showed increased body weight of approximately 
30% in the young adult ages (2–5 months) related an increase in muscle mass. Compared to 
the wild type, the pectoralis muscles of the myostatin knockout mice increase up to 262%. 
This increase in muscle mass was due to the hyperplasia or increased number of muscle 
fibers (82% increase in the tibialis anterior muscle fibers) as well as hypertrophy or increase 
in the cross-sectional area of individual fibers (14% in tibialis anterior fibers muscle and 49% 
in the gastrocnemius fibers muscle) [69,70,75]. Also, when myostatin knockout mice were 
examined at an older age (9 month), they still revealed excessive muscle size however the 
total body weight had been normalized compared to the wild type animal. The body weight 
normalization despite the presence of excessive muscle mass was due to the deficit in body 
fat development. Decreased fat accumulation in myostatin knockout mice resulted from a 
decrease in number as well as size of adipocytes [74]. 
To study the mechanisms of action of myostatin on skeletal muscle development, most 
investigators treated muscle precursor cells with recombinant myostatin protein. A number 
of studies have been performed in vitro on C2C12 myoblast cell lines and in vivo during 
chick embryonic muscle development, which showed that myostatin prevented 
proliferation and differentiation of muscle cells precursors [76,77]. Myostatin induced 
expression of the cell cycle inhibitors p21 [78] and inhibited expression of myogenic 
regulatory factors, which encode transcription factors regulating muscle differentiation [79]. 
Conversely, lack of myostatin should stimulate proliferation and differentiation of muscle 
precursors. In agreement with this hypothesis, McCroskery et al. [80] showed that satellite 
cells, normally a quiescent muscle stem cell population required to repair and regeneration 
of adult muscle, were increased in number relative to the myonuclei of the muscle fibers and 
showed increased proliferation rates in myostatin knockout mice. In contrast, there are 
studies which these satellite cells did not proliferate more than those from wild type animals 
[75].  
The myostatin gene encodes a small signal sequence at the N-terminus followed by a large 
pro-peptide region (also called the latency association protein or LAP-fragment) and a 
smaller mature region at the C-terminus [69]. The signal sequence is required for processing 
and secretion. The pro-peptide region regulates the biological activity of myostatin. The 
mature region binds to one of the two Activin type II receptors (ActRIIB to a greater degree 
than ActRIIA) a family of serine/threonine kinase transmembrane receptors on target cells 
[70]. Binding of the ligand to ActRIIA/B, leads to the phosphorylation and activation of the 
Activin type I receptor, which in turn initiates the intracellular signalling cascade by 
phosphorylating the receptor-regulated proteins Smad2 and Smad3. Upon phosphorylation 
Smads form heterodimers with a Co-Smad, Smad4, and these activated Smad complexes 
translocate from the cytoplasm to the nucleus where they regulate transcription of target 
genes [79,81] (Figure 2). 
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Myostatin is found as inactive complex in plasma and muscle tissue of humans and mice, 
and the action of proteases making it active by cleavage of the pro-peptide region releasing 
the mature region [82]. Interestingly, Yang et al. [83] created transgenic mice that 
overexpressed the myostatin propeptide under the control of the Myosin Light Chain (MLC) 
promotor. In this study resulted in an increase of carcass weight of 48% at 18 weeks. 
Morphometric analysis revealed an increase in fiber diameter but no in fiber number. The 
ability of myostatin to inhibit muscle growth may therefore not necessarily rely solely on 
gene transcription but could also be reliant upon its availability from the extracellular 
matrix. This proposes a link between the integrity of the extracellular matrix to myostatin 
activity. This point is significant since there is extensive remodeling of the extracellular 
matrix during muscle degeneration/ regeneration increasing growth regulatory proteins 
synthesis [75]. 
Although the mechanisms of activation are not well known, specific factors also are 
responsible for generating the active species and subsequent inhibitory activity of myostatin 
[84]. The following myostatin binding proteins have been identified to date: Activin 
Receptor, Follistatin and the Follistatin related proteins FLRG (Follistatin Related Gene) and 
GASP-1 (Growth and Differentiation Factor-Associated Serum Protein-1). In addition, 
specific antibodies have been developed which bind and inactivate myostatin [70,75,84,85]. 
Lee and McPherron [70] have created transgenic mice expressing a dominant negative form 
of the Activin II receptor. This was achieved by expressing a truncated form of the receptor 
that lacked the intracellular kinase domain.Therefore, although the truncated receptor 
would still be able to bind myostatin, it would not be able to activate the signal transduction 
cascade. Over-expression of the truncated form of the receptor led to significant increases in 
muscle mass, which resulted from hyperplasia (27%) as well as hypertrophy (19%). Whilst 
not suitable in a clinical setting, the genetic approach does highlight that the Activin 
receptor could be targeted to promote muscle development through the development of 
receptor inhibitors. However, it is important to emphasize that the presence of non-
functional Activin receptor leads to infertility [85]. 
The follistatin is expressed in different tissues and acts as an antagonist of different family 
members TGF-β [86]. A study in knockout mice for the gene of follistatin observed excessive 
loss of muscle mass [85]. On the other hand, follistatin overexpression mice showed 327% 
increase in muscle mass compared to control group [70]. The excessive increase in muscle 
mass observed in these mice resulted from the combination of muscle hypertrophy (27%) 
and hyperplasia (66%). Recent studies show a high affinity and direct interaction of 
follistatin to myostatin [87], suggesting its direct action in controlling the activity of 
myostatin. Remarkably, the increase in muscle mass was far greater than that observed 
following the deletion of the myostatin gene [69]. One possible explanation for these 
differences is that follistatin is likely to antagonize molecules in addition to myostatin that 
also act as muscle growth inhibitors. Introducing a structure homologous to follistatin, the 
FLRG can also play an important role in the regulation of myostatin [88], by binding to its 
mature region and inhibiting its biological activity. 
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Other possible myostatin inhibitor is the GASP-1, which contains domains that are serine 
protease inhibitors. The GASP-1 interacts with both regions of the myostatin negatively 
regulates its activity by inhibiting the activity of proteases on the myostatin preventing the 
release of the mature region [89].  
Several studies showed mutations in the myostatin gene related to skeletal muscle 
hypertrophic phenotype. Double muscling is a trait previously described in several 
mammalian species including mice [90], cattle [91,92], sheep [93], and human, the latter 
described once in a German boy [94] and is caused by mutations in the myostatin gene. 
Mosher et al. [95] have discovered a 2-bp deletion in the whippet myostatin gene that in the 
homozygote state results in a double-muscling phenotype commonly referred to as the 
‘‘bully’’ whippet. This deletion causes a premature truncation of the protein, removing the 
latter 17% of the protein. The whippet breed was developed in the late 1800s specifically for 
the sport of racing. Despite its comparatively small stature it is a very fast dog capable of 
running up to 35 miles per hour [95]. Studies of muscle composition in myostatin knockout 
mice demonstrate a higher proportion of both fast type II and glycolytic fibers, versus slow 
type I and oxidative fibers when compared to wild-type mice [96]. In addition, the glycolytic 
muscle phenotype of myostatin knockout mice is associated with a decrease in capillary 
density, mitochondrial number and expression of mitochondrial enzymes [69,97]. While this 
change in muscle composition may offer an advantage to whippets, which typically race a 
short sprint of 200-300m, it may be disadvantageous to whose races extend to 900m and 
where endurance is more important. 
These findings have implications for competitive and professional sports. Studies show that 
a disruption in the function of the myostatin gene can increase an individual’s overall 
athletic performance in a robust and measurable way. To date, the muscular hypertrophy 
phenotype has been described in a single human child [94]. This child possessed two copies 
of a G-to-A transition in the noncoding region of the human myostatin gene. This mutation 
results in the mis-splicing of precursor mRNA, which most likely truncates the myostatin 
protein. The child’s mother, a former professional athlete, was heterozygous for this 
mutation and also appeared muscular, although not to the same degree as her child. As 
discussed by several authors, human athletes could undergo so-called gene doping via 
disruption of myostatin. The potential to increase an athlete’s performance by disrupting 
myostatin either by natural or perhaps artificial means could change the face of competitive 
human and canine athletics. Given the poorly understood consequences for overall health 
and well-being, caution should be exercised when acting upon these results [95]. 
Interestingly, recent studies show that the increase in muscle mass induced by exercise 
training may be related to the regulation of myostatin [98]. Treadmill-trained rats showed 
decreased expression of myostatin in gastrocnemius and vastus lateralis muscles, showing 
that exercise training is effective in reducing the levels of this protein [99]. However, a study 
comparing the effects of endurance exercise and resistance training on the expression of 
myostatin showed different times of myostatin gene expression between the modalities. The 
aerobic training reduced the expression of myostatin from 8-12 hours after the session, and 
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this effect was less pronounced when compared to resistance training, where the reduced 
expression of myostatin was observed 1-24 hours after the training session [100] (Figure 2). 
Resistance training led to decreased expression of myostatin in 73% in active muscles [101]. 
The reduction in myostatin expression was observed in a single session and after 9 week of 
traditional high-intensity (i.e., 75%-85% one-repetition maximum) resistance exercise (34%) 
[98,101]. These findings suggest that downregulation of myostatin gene after exercise may 
result in greater muscle hypertrophy in a training program. Accordingly, Laurentino et al. 
[102] showed that increased in muscle strength and hypertrophy responses observed after 
either low-intensity resistance exercise associated with moderate blood flow restriction or 
high-intensity resistance exercise were related with similar changes in selected myostatin-
related genes mRNA expression. The authors found reduction in myostatin gene and a 
trend in Activin IIb mRNA expression after 8 weeks of training in both the protocols. 
Interestingly, the study also report significant increases in GASP-1 and Smad-7 gene 
expression after exercise training. Furthermore, studies show that in elderly who underwent 
strength training was observed decreased expression of myostatin in 48% after the last 
training session only in trained subjects, however, was observed desensitization of the 
receptor Activin IIb, even after a single exercise session [98] (Figure 2). However, reduction 
in myostatin expression induced by exercise is still controversial. In rats, it was observed 
increased expression of myostatin after 30 minutes in a single session of eccentric exercise 
[103]. Studies show that resistance training increased muscle expression of myostatin and its 
circulating levels [104]. It may be speculated that these dissonant findings are related to the 
timing of the biopsy after the last training session, once that studies performed posttraining 
biopsies 48-72 h after the last training session, whereas others collected the samples only 15 
min after it. Therefore, it is possible that these findings may reflect acute and training 
program effects, respectively.  
Studies on the expression of myostatin-related loss of muscle mass promoted by physical 
detraining were developed. Jespersen et al. [105] performed muscle biopsies obtained from 
young male subjects before and after 30 and 90 days of resistance training as well as after 3, 
10, 30, 60 and 90 days of subsequent detraining. Myostatin mRNA increased significantly 
with detraining. Further, they observed a significant increase in this expression after 3 days 
of detraining preceding the rapid type II fiber atrophy, in which almost half of the acquired 
fiber area was lost after only 10 days of detraining. Thus, the data suggest a role for 
myostatin in the negative regulation of adult human skeletal muscle mass. 
In contrast to the canonical view of skeletal muscle structure and function, the muscle 
hypertrophy that develops in the absence of myostatin is not accompanied by proportionate 
increase in contraction strength [106], however, recent evidence suggested that endurance 
exercise training may normalize the muscle phenotype induced by the absence of myostatin 
[107,108]. Matsakas et al. [108] showed that two different types of endurance training, 
voluntary wheel running and swimming reduced muscle fiber size, increased muscle 
oxidative properties, increased capillary density and, most importantly, improved force 
generation in the myostatin null mouse. Thus, these results demonstrate that features 
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induced by a germ-line deletion of myostatin are not genetically locked down but can be 
modified by exercise training (Figure 2).  
 
Figure 2. Effect of exercise training on skeletal muscle myostatin expression. Inactive myostatin 
(propeptide portion forms non-covalent link to mature portion) is secreted by muscle cells. Proteases on 
muscle cells release propeptide from mature region. Mature region binds type II Activin receptor. 
Transphosphorylation leads to activation of type I receptor which it phosphorilates Smad2/3 facilitating 
the translocation into nucleus where it initiates genes transcription related to cell growth and metabolic 
change toward glycolitic profile. Interestingly, aerobic and strength training reduce skeletal muscle 
myostatin expression associated to increase muscle strength, hypertrophy and metabolic homeostasis  
Myostatin may be related pathways that contribute to muscle regeneration after exercise. 
Consequently, these changes will depend on the conditions myostatin muscle before 
exercise. Studies comparing people with different types of training prior show that the 
response of myostatin can be altered with resistance exercise [109]. This hypothesis is 
strengthened by the fact that myostatin expression is increased in response to elevated 
serum levels of glucocorticoids. The regulatory region of the myostatin gene contains 
sequences activating responsive to glucocorticoids [110]. Thus, the increase in protein may 
be due to stress caused by exercise training [104]. However, studies have shown that 
increased expression of myostatin induced by exercise occurred concomitantly with 
increasing of FLRG and decreasing Activin receptor IIb levels, suggesting that the increase 
in FLRG can inhibit the myostatin activity in those cases, occurring mechanism 
compensatory increase the myostatin [88]. 
In cardiovascular diseases as late-stage chronic heart failure and diabetes, elevated cytokines 
and cachexia are often observed. Several studies have shown that exercise training exerts 
beneficial effects on skeletal muscle in this setting. Furthermore, it has been shown that the 
expression of myostatin is increased in a variety of cachectic states. Myostatin is capable of 
inducing muscle atrophy via its inhibition of myoblast proliferation, increasing ubiquitin-
proteasomal activity and downregulating activity of the IGF–Akt pathway [111-113]. 
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Remarkably, exercise training on a treadmill over 4 weeks led to a significant reduction in 
myostatin protein expression in the skeletal muscle and the myocardium of chronic heart 
failure animals, with values returning to baseline levels [111]. In addition, chronic heart 
failure patients showed a two-fold increase of myostatin mRNA and a 1.7-fold 
augmentation of protein content in skeletal muscle compared to healthy subjects. However, 
exercise training led to a 36% reduction of the mRNA and a 23% decrease of the myostatin 
protein compared to baseline [112]. Accordingly, myostatin, its receptors and follistatin 
expression change in both muscle and fat of diabetic rats and their expressions can be 
modulated by exercise in diabetes [113]. These alterations in myostatin expression in the 
skeletal muscle following exercise training could help to explain the beneficial anti-catabolic 
effects of exercise training in cardiovascular diseases. 
In conclusion, this approach appears to have important inhibitory role for the hypertrophy 
induced by both aerobic and resistance exercise by being used as a negative regulator of 
hypertrophy. However, we need more studies to establish a direct relationship between this 
protein and hypertrophy induced by exercise and thus clarify the role of changes in their 
expression after a workout, both in aerobic and resistance exercises.  
5. Skeletal muscle and microRNAs  
Skeletal muscle cells arise from embryonic mesoderm during embryonic development, 
where they exist as proliferating myoblasts or terminally differentiated myotubes that have 
exited the cell cycle [114]. Recent studies have revealed that, in addition to activating genes 
involved in muscle differentiation and muscle contraction, these myogenic transcription 
factors activate the expression of a set of conserved microRNAs (miRNAs) that function to 
“fine-tune” the output of these transcriptional networks, resulting in accurate cellular 
responses to developmental, physiologic and pathologic signals [114-116]. 
MiRNAs are a class of short, non-coding RNA molecules that reportedly play a central role 
in regulating post-transcriptional gene expression during embryonic stem cell development, 
myogenesis, adipogenesis, fat metabolism and glucose homeostasis [116]. MiRNAs are ~22 
nucleotides long and inhibit translation or promote mRNA degradation by annealing to 
complementary sequences in the 3´untranslated regions (UTRs) of specific target mRNAs. It 
is estimated that there are more than 1500 miRNAs encoded by the human genome, roughly 
equaling the number of transcription factors [117]. The power of miRNAs as regulators of 
gene expression is also underscored by recent study demonstrating their ability to up-
regulate translation of specific targets [118]. 
Approximately 50% of mammalian miRNAs loci are found in close proximity to other 
miRNAs. These clustered miRNAs are transcribed from a single polycistronic transcription 
unit (TU), although there may be exceptional cases in which individual miRNAs are derived 
from separate gene promoters. Some miRNAs are generated from non-coding TUs, whereas 
others are encoded in protein-coding TUs. Approximately 40% of miRNAs loci are located 
in the intronic region of non-coding transcripts, whereas ~10% are placed in the exonic 
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region non-coding TUs. MiRNAs in protein-coding TUs are usually found in intronic 
regions. Some mixed miRNA genes can be assigned to either intronic or exonic miRNA 
groups depending on the alternative splicing patterns [119].  
Most miRNAs are transcribed by DNA-dependent RNA polymerase II (RNAPII) to generate 
a primary miRNA (pri-miRNAs) is processed in the nucleus by the RNase Drosha, yielding 
stem-loop structures of ~70 nucleotides. These precursor (pre-miRNAs) are transported to 
the cytoplasm by the nuclear export protein, Exportin 5, where they are further processed by 
the RNAse Dicer, giving rise to the mature miRNA and its complementary strand from the 
stem-loop, referred to as the ´star` strand [5]. The mature miRNA is incorporated into the 
RNA-induced silencing complex (RISC), where acts by hybridizing either perfectly or 
partially to complementary binding sites located in the 3`UTRs of target mRNAs, promoting 
translational repression or degradation [115,119] (Figure 3). 
 
Figure 3. The Current model for the biogenesis and post-transcriptional supresssion of microRNAs – 
MicroRNAs are generally transcribed by RNA polymerase II (RNAPII) to yield primary miRNAs (pri-
miRNA) transcripts are first processed into ~70 nucleotide pre-miRNAs by Drosha inside nucleus. Pre-
miRNAs are transported to the cytoplasm by Exportin 5 and are processed into miRNAs by Dicer. Only 
one strand of the miRNA duplex is preferentially assembled into the RNA-induced silencing complex 
(RISC), which subsequently acts on its target by translational repression. ORF, open reading frame. 
Recent evidence supports a role for miRNAs as integral components of the regulatory 
circuitry for muscle development [120]. In skeletal muscle, miRNA-1, miRNA-133a, miRNA-
133b, and miRNA-206 together account for nearly 25% of all miRNA expression and are as a 
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group often referred to as myomiRNAs [121]. The expression of myomiRNAs is 
dramatically increased during myogenesis. Furthermore, differential expression of 
myomiRNAs following resistance exercise in skeletal muscle suggests that myomiRNAs 
play a role in human health [115].  
The functional characterization of miRNA-1, miRNA-133a, miRNA-133b and miRNA-206, 
has been an important step in our understanding of miRNA-mediated muscle development.  
Studies have demonstrated that miRNA-1 and miRNA-133 regulate fundamental aspects of 
muscle biology such as differentiation and proliferation. In C2C12 skeletal muscle cells, 
miRNA-1 represses the expression of histone deacetylase 4 (HDAC4), a negative regulator 
of differentiation and a repressor of the MEF2 (transcription factor). Thus, the repression of 
HDAC4 by miRNA-1 establishes a positive feed-forward loop in which the up-regulation of 
miRNA-1 by MEF2 causes further repression of HDAC4 and increased activity of MEF2, 
which drives myocyte differentiation [116]. In C2C12 myoblasts, the ability of miRNA-133 to 
promote proliferation has been ascribed to the repression of SRF (serum response factor), an 
essential regulator of muscle differentiation. MiRNA-133 also represses translation of the 
polypyrimidine tract-binding protein (nPTB), which promotes differential splicing of a 
variety of transcripts that influence the muscle differentiation program [122]. In addition, 
CHIP on CHIP analysis also indicated that the myogenic regulatory factors, MYOD1 and 
Myogenin, bind to sequences upstream of miRNA-1 and miRNA-133. It seems as miRNA-1 
and miRNA-133 that are encoded by the same MEF2-regulated bicistronic transcripts would 
exert opposing effects on muscle growth and differentiation. However, both miRNA-1 and 
miRNA-133 fine tune key regulatory pathways in an antagonistic manner with the balance 
being tipped one way or the other by additional transcription factors and regulatory 
pathways. While experiments in cell culture suggested that miRNA-1 and miRNA-206 
promote differentiation of myoblasts, miRNA-133 has been proposed to promote myoblast 
proliferation, a role opposite to that of miRNA-1 through down-regulation of different 
target gene [120]. 
Most recently, miRNA-1 and miRNA-133 were shown to play regulatory a role in apoptosis. 
MiRNA-1 mediated a pro-apoptotic effect, while the effect of miRNA-133 was anti-apoptotic 
[123]. Thus, in addition to their role in regulating muscle cell proliferation and 
differentiation, miRNA-1 and miRNA-133 also seem to play opposing roles in regulating 
muscle cell apoptosis. The opposing effects of miRNA-1 and miRNA-133 during apoptosis 
are likely explained by which genes are targeted: miRNA-1 reduced protein levels of HSP60 
and HSP70, while miRNA-133 repressed caspase-9 expression [123]. Though a clear picture 
of which genes are regulated by miRNAs is desperately needed to fully understand the roles 
of miRNAs in muscle biology, the main theme that has emerged thus far is that miRNAs 
indeed participate in regulatory networks modulate muscle gene expression, muscle cell 
proliferation, differentiation, and apoptosis [124, 125]. 
MiRNA-206 is one the most abundant miRNAs in adult skeletal muscle. The function of 
miRNA-206 in adult skeletal muscle remains to be determined but given the importance of 
the muscle-specific miRNAs in muscle development, it is reasonable to propose an 
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important role for myomiRNAs in skeletal muscle plasticity in the adult animal. Recent 
study determined the expression of precursor and mature forms of the established 
myomiRNAs in the soleus and plantaris muscles and in the plantaris during the initial stage 
of muscle hypertrophy. Interestingly, expression of miRNA-206 was 7-fold higher in the 
soleus muscle in comparison to the plantaris muscle suggesting miRNA-206 may have some 
role in a specifically setting fiber type. During skeletal muscle hypertrophy induced by 
synergist ablation, transcript level of precursor miRNA-206 (pri-miRNA-206) was elevated 
18.3 fold whereas expression of miRNA-206 did not significantly change. The reason for this 
post-transcriptional regulation of miRNA-206 during muscle hypertrophy is not known but 
the authors suggested it might be the result of competitive inhibition of Drosha by 
ribosomal RNA (rRNA). Whatever the reason for the discordant expression of pri-miRNA-
206 and miRNA-206 during hypertrophy, it would be of interest to determine if at a later 
time point, when the fast-to-slow fiber type transition is known to occur, if there is an 
increase miRNA-206 expression comparable to pri-miRNA-206 levels. If this scenario was 
found to be the true, it would provide further evidence to support the idea that miRNA-206 
is involved in regulating fiber types [126,127]. 
The miRNA-206 has been characterized as a muscle regulator and has also been shown to 
promote myoblast differentiation. Gap junction protein connexin43 (Cx43) and the p180 
subunit (Pola1) of DNA polymerase alpha have been identified as regulatory targets of 
miRNA-206. Although Cx43 is required for the initial phase of myogenesis, it is rapidly 
down-regulated post-transcriptionally after the induction of differentiation, thus miRNA-
206 is suggested to decreased communication between development muscle fibers 
decreasing Cx43 expression [128-130]. Down-regulation of Pola1 by miRNA-206 during 
early differentiation reduces DNA synthesis and contributes to the suppression of cell 
proliferation during myotube formation. MiRNA-206 is also suggested to mediate MyoD-
dependent inhibition of follistatin-like 1 (FSTL1) and Utrophin (Utrn) genes in myoblasts. In 
this case, MYOD1 activates the expression of miRNA- 206, which in turn represses FSTL1 
and Utrn gene expression post-transcriptionally. This mechanism could explain some of the 
previous observations in which MYOD1, known as a transcriptional activator, repressed 
FSTL1 and Utrn gene expression. Although Utrn expression was repressed by miRNA-206 
during myoblast differentiation, its expression was up-regulated in mdx diaphragm muscle. 
This phenomenon might reflect decreased efficiency of miRNA-mediated translational 
repression during a diseased state [120,130,131]. 
Interestingly, recent studies show that miRNA-214 is expressed in skeletal muscle cell 
progenitors during zebrafish development and was shown to specify muscle cell type 
during somitogeneses by modulating the response of muscle progenitors to Hedgehog 
signaling. Blocking miRNA-214 activity by injecting chemically-modified antisense 
oligonucleotides into zebrafish embryos decreased in the number of slow-muscle cell types 
present in the developing somites and distinctly changed the gross morphology of the 
somites in manner previously associated with attenuated Hedgehog signaling. This 
phenotype was attributed to relief of miRNA-214-mediated inhibition of suppressor of fused 
(su(fu)) expression , a fine tuner of Hedgehog signaling essential for proper specification of 
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muscle cell types during somitogeneses [120,132]. It will be interesting to test whether 
miRNA-214 plays a similar role in mammalian skeletal muscle development. Collectively, 
these studies indicate that miRNAs function as regulators of gene expression important for 
myoblast proliferation and differentiation and may play decisive roles in specifying cell 
types during development [120]. 
In contrast to the other muscle miRNAs discussed, which are specifically expressed in a 
tissue-restricted manner, miRNA-181 is broadly expressed. Interestingly, the expression of 
miRNA-181 was increased in the regenerating muscle from an in vivo mouse model of 
muscle injury [133]. Further analysis using the C2C12 cell line demonstrated that miRNA-
181 depletion reduced MyoD expression and inhibited myoblast differentiation. One of the 
genes targeted by miRNA-181 is homeobox protein Hox-A11, which in turn represses MyoD 
expression. The proposed mechanism underlying miRNA-181 function is that miRNA-181 
becomes up-regulated upon differentiation and targets a repressor (Hox-A11) of the 
differentiation process to allow new muscle growth. This study suggests that miRNAs can 
play roles in establishing a differentiated phenotype and alludes to the potential role of 
miRNAs in skeletal muscle regeneration. In addition to myogenesis, miRNA-181 was shown 
to modulate hematopoietic lineage differentiation in another study [134], which suggests 
that individual miRNAs may play very diverse biological roles depending upon their 
cellular context [120]. 
Non-muscle specific miRNAs that contribute to the maturation of myoblasts is miRNA-29, 
which functions as an enhancer of skeletal myogenesis [135]. In the attempt to identify other 
miRNAs involved in muscle development, Huang and co-workers performed a global 
miRNAs expression analysis from porcine skeletal muscle collected in 33-day and 65-day 
post-gestation fetuses, as well as in adult tissue. Their results revealed that the miRNA-29 
family members are strongly regulated during development as the highest expression of all 
three miRNA-29 members occurred in adult muscle tissue [136]. Additional miRNAs array 
analysis from a broad spectrum of muscular dystrophies affirmed the expression of miRNA-
29 in skeletal muscle and further described the associated reduction of this miRNA in 
multiple muscle disorders that included Duchenne muscular dystrophy, 
facioscapulohumeral muscular dystrophy, and nemaline myopathy [137,138]. 
Our understanding of miRNAs biology is still incipient. It has been estimated that at least 
one this mammalian genes are regulated by as many as a thousand miRNAs, only a few of 
which have been studied in any detail. An important challenge for the future will be to 
identify the downstream targets that mediate the actions of miRNAs in development. The 
ability of mutations or single nucleotide polymorphisms to destroy, alter or create new 
target sequences for miRNAs represents an intriguing source of phenotypic variation. Such 
polymorphisms will likely be difficult to identify, given the degeneracy within miRNA-
mRNA interactions and relatively short sequences of miRNAs and their targets. Finally, 
although muscle has been among the most intensely studied cell type with respect to the 
regulation and mechanisms of action of miRNAs, the principles learned from muscle will 
undoubtedly apply to other cell types. 
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6. Conclusion 
Considerable progress has been made in understanding the signaling pathways that 
mediate the hypertrophy and atrophy of skeletal muscle. The present literature supports the 
role of activation of signaling pathways intracellular Akt- mTOR, myostatin and skeletal 
muscle miRNAs in regulating hypertrophic by increasing muscle protein synthesis induced 
by exercise training. However, the mechanisms that regulate this process are quite complex 
and sometimes controversial in the literature, requiring greater effort and future studies to 
further elucidation. 
As already mentioned, the objective of this review was to identify and discuss the main 
factors in the literature as capable of generating the hypertrophic response, ie the various 
intracellular signaling pathways that produce the biochemical responses promoters of 
increasing muscle fiber size. Certainly, there are other avenues to be considered, but these 
identified here may be regarded as the most studied and best representing the complex 
signaling system responsible for the intracellular skeletal muscle trophism induced by 
exercise training.  
Regimes that can stimulate muscle growth and prevent muscle loss are likely to benefit a 
significant proportion of the population. These findings may greatly contribute to the 
importance of exercise training in future interventions pharmacological and clinical, 
especially for prevention and control of diseases, as well as for future insertions sports 
performance, rehabilitation and aging.  
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